Skip to main content

$0.040 0.004 (11.11%)

High

$0.04

Low

$0.04

Trades

37

Turnover

$81,892

Volume

2,106,389
30 June 2023 at 3:45pm
Register to track NTI and receive email alerts.

Further Success with Preclinical Testing Program - MS Models

StockBot

416,823 posts

NTI released this announcement to the ASX on 7 July 2021, 9:29. The announcement is not marked as price sensitive, and is 2 page(s) in length and 147.75kb in size.

You can view all announcements from NTI and see how they appear on a price chart on the announcements page.

At the date of this announcement, NTI was 0.086% short sold according to ASIC data. It was ranked the 486th most shorted stock on the ASX. It remains ranked 538th as of the latest reported data (23 January 2026).

Other Recent Announcements from NTI
Notification of cessation of securities - NTI 30 June 2023, 17:06
Notification regarding unquoted securities - NTI 28 June 2023, 16:14
NTI to Present at Rett Syndrome Foundation Meeting 5 June 2023, 8:27
Further Success with Preclinical Testing Program - MS Models 7 July 2021, 9:29
Appendix 3G 1 July 2021, 9:25
Update - Proposed issue of securities - NTI 29 June 2021, 17:19
NTI to Present at the Gold Coast Investment Showcase 23 June 2021, 9:46
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track NTI and receive email alerts.